Enhanced antitumor activity by a selective conditionally replicating adenovirus combining with MDA-7/interleukin-24 for B-lymphoblastic leukemia via induction of apoptosis

References

Page 1

	Year	Citations
Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachment Thomas J. Wickham, Patricia Mathias, David A. Cheresh, Cell Molecular VirologyPathogenesisViral PathogenesisImmunologyVirology	1993	2.2K
An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells James R. Bischoff, David H. Kirn, Angelica Williams, Science Mutant AdenovirusAdenovirus MutantFunctional P53Mutant AdenovirusesMedicine	1996	1.8K
Phase II Trial of Intratumoral Administration of ONYX-015, a Replication-Selective Adenovirus, in Patients With Refractory Head and Neck Cancer John Nemunaitis, Fadlo R. Khuri, Ian Ganly, Journal of Clinical Oncology	2001	472
LOSS OF ADENOVIRAL RECEPTOR EXPRESSION IN HUMAN BLADDER CANCER CELLS- A POTENTIAL IMPACT ON THE EFFICACY OF GENE THERAPY Rey-Chen Pong, Yingming Li, M. Craig Hall, The Journal of Urology UrologyGenitourinary CancerMedicineTumor SuppressorCancer Biology	1999	345
Hepatic arterial infusion of a replication-selective oncolytic adenovirus (dl1520): phase II viral, immunologic, and clinical endpoints. Tony Reid, E. Galanis, James L. Abbruzzese, PubMed Viral ReplicationReplication-selective Oncolytic AdenovirusImmunologyPathologyReplication-selective Oncolytic Adenoviruses	2002	310
<i>mda-</i> 7 (IL-24) mediates selective apoptosis in human melanoma cells by inducing the coordinated overexpression of the GADD family of genes by means of p38 MAPK Devanand Sarkar, Zao-zhong Su, Irina V. Lebedeva, Proceedings of the National Academy of Sciences Gadd FamilyTumor BiologyCancer ImmunosurveillanceSubtraction HybridizationMedicine	2002	304
Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial Sean J. Mulvihill, Robert S. Warren, Alan P. Venook, Gene Therapy Replication-selective AdenovirusE1b-55 KdaPancreatic CancerPrimary CarcinomasMedicine	2001	301
Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: safety, feasibility and biological activity John Nemunaitis, Casey Cunningham, A Buchanan, Gene Therapy Intravenous InfusionReplication-selective AdenovirusViral ReplicationOncologyPathology	2001	280
The cancer growth suppressor gene <i>mda-</i> 7 selectively induces apoptosis in human breast cancer cells and inhibits tumor growth in nude mice Zao-zhong Su, Malavi T. Madireddi, Jiao Jiao Lin, Proceedings of the National Academy of Sciences	1998	254
Phase I Trial of Intraperitoneal Injection of the E1B-55-kd-Gene-Deleted Adenovirus ONYX-015 (dl1520) Given on Days 1 Through 5 Every 3 Weeks in Patients With Recurrent/Refractory Epithelial Ovarian Cancer P. Vasey Journal of Clinical Oncology	2002	249

Page 1